Drugs & Targets AstraZeneca, Thermo Fisher to develop develop solid tissue and blood-based companion diagnostic for Tagrisso January 27, 2023Vol.49 No.04
Drugs & Targets AstraZeneca, Ibex collaborate on AI-powered HER2 scoring product January 27, 2023Vol.49 No.04
Drugs & Targets Evotec, Janssen collaborate to develop immune-based therapies January 27, 2023Vol.49 No.04
Drugs & Targets Tukysa + trastuzumab receives FDA accelerated approval for previously treated metastatic CRC January 20, 2023Vol.49 No.03
Drugs & Targets FDA publishes draft guidance on optimizing dosage for oncology drugs January 20, 2023Vol.49 No.03
Drugs & Targets Strata Oncology adds Gilead as Strata PATH Trial collaborator January 20, 2023Vol.49 No.03
Drugs & Targets Elicio Therapeutics and Angion enter into merger agreement to advance cancer vaccine January 20, 2023Vol.49 No.03
Drugs & Targets Foundation Medicine & Natera provide early access to personalized circulating tumor DNA monitoring assay January 13, 2023Vol.49 No.02
Drugs & Targets Kronos Bio & Genentech to collaborate on therapies against transcriptional targets January 13, 2023Vol.49 No.02
